

Best Seller
KLOW 80 mg
For Research Purposes Only. Not for Human Consumption.
Bundle & save
Add 1 more to save 5%.
- Credit or debit card
ZelleCash App
Afterpay
No payment is taken on this site — instructions follow by email.
About this compound
KLOW is a multi-peptide research blend containing 50MG GHK-Cu, 10MG TB-500, 10MG BPC-157, and 10MG KPV, studied in models involving tissue-response signaling, skin biology, inflammatory pathways, connective tissue research, epithelial barrier biology, and cellular remodeling.
For laboratory research use only. Not for human or veterinary consumption, and not for use in diagnostic procedures.
Frequently researched together
Compounds commonly studied alongside this one.
Peer-reviewed literature
Published research in which this compound appears, for research context.
- 01
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Reviews gene-expression data underlying GHK-Cu activity, including wound contraction, epithelialisation and antioxidant enzyme activity.
- 02
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Examines tendon fibroblast outgrowth, survival under stress and migration in vitro, implicating the FAK–paxillin pathway.
- 03
Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review
Maps 80 studies across the TB4/TB-500 literature and notes that the evidence base is largely preclinical, with most work evaluating TB4 rather than TB-500 itself.
- 04
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
Evaluates KPV in DSS colitis and CD45RB-high transfer colitis models with histology and MPO endpoints.
These references describe the scientific literature in which this compound appears. They are not claims about this product, and nothing here suggests a use in humans. All products are supplied strictly for laboratory research.

